These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 39259072)
1. The efficacy and safety of ginger (Zingiber officinale) rhizome extract in outpatients with COVID-19: A randomized double-blind placebo-control clinical trial. Ameri A; Farashahinejad M; Davoodian P; Safa O; Hassaniazad M; Parsaii M; Heidari B; Hassanipour S; Akhlaghi B; Fathalipour M Medicine (Baltimore); 2024 May; 103(22):e38289. PubMed ID: 39259072 [TBL] [Abstract][Full Text] [Related]
2. Effects of Ginger on clinical manifestations and paraclinical features of patients with Severe Acute Respiratory Syndrome due to COVID-19: A structured summary of a study protocol for a randomized controlled trial. Safa O; Hassaniazad M; Farashahinejad M; Davoodian P; Dadvand H; Hassanipour S; Fathalipour M Trials; 2020 Oct; 21(1):841. PubMed ID: 33036662 [TBL] [Abstract][Full Text] [Related]
3. Ivermectin for preventing and treating COVID-19. Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930 [TBL] [Abstract][Full Text] [Related]
4. Effect of Zingiber officinale R. rhizomes (ginger) on pain relief in primary dysmenorrhea: a placebo randomized trial. Rahnama P; Montazeri A; Huseini HF; Kianbakht S; Naseri M BMC Complement Altern Med; 2012 Jul; 12():92. PubMed ID: 22781186 [TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
6. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
7. The effect of frankincense (Boswellia serrata, oleoresin) and ginger (Zingiber officinale, rhizoma) on heavy menstrual bleeding: A randomized, placebo-controlled, clinical trial. Eshaghian R; Mazaheri M; Ghanadian M; Rouholamin S; Feizi A; Babaeian M Complement Ther Med; 2019 Feb; 42():42-47. PubMed ID: 30670277 [TBL] [Abstract][Full Text] [Related]
8. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial. Vallejos J; Zoni R; Bangher M; Villamandos S; Bobadilla A; Plano F; Campias C; Chaparro Campias E; Achinelli F; Guglielmone HA; Ojeda J; Medina F; Farizano Salazar D; Andino G; Ruiz Diaz NE; Kawerin P; Meza E; Dellamea S; Aquino A; Flores V; Martemucci CN; Vernengo MM; Martinez SM; Segovia JE; Aguirre MG Trials; 2020 Nov; 21(1):965. PubMed ID: 33234158 [TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial. Akova M; Unal S Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629 [TBL] [Abstract][Full Text] [Related]
10. Ivermectin for preventing and treating COVID-19. Popp M; Reis S; Schießer S; Hausinger RI; Stegemann M; Metzendorf MI; Kranke P; Meybohm P; Skoetz N; Weibel S Cochrane Database Syst Rev; 2022 Jun; 6(6):CD015017. PubMed ID: 35726131 [TBL] [Abstract][Full Text] [Related]
11. Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial. Brown LK; Freemantle N; Breuer J; Dehbi HM; Chowdhury K; Jones G; Ikeji F; Ndoutoumou A; Santhirakumar K; Longley N; Checkley AM; Standing JF; Lowe DM Trials; 2021 Mar; 22(1):193. PubMed ID: 33685502 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of licorice (Glycyrrhiza glabra) in moderately ill patients with COVID-19: a randomized controlled trial. Ameri A; Farashahinejad M; Davoodian P; Safa O; Kusha A; Dadvand H; Hassanipour S; Fathalipour M Inflammopharmacology; 2023 Dec; 31(6):3037-3045. PubMed ID: 37847472 [TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of herbal extracts to restore respiratory health and improve innate immunity in COVID-19 positive patients with mild to moderate severity: A structured summary of a study protocol for a randomised controlled trial. Rangnekar H; Patankar S; Suryawanshi K; Soni P Trials; 2020 Nov; 21(1):943. PubMed ID: 33225970 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of deferoxamine in moderately ill COVID-19 patients: An open label, randomized controlled trial. Ameri A; Pourseyedi F; Davoodian P; Safa O; Hassanipour S; Fathalipour M Medicine (Baltimore); 2024 Aug; 103(34):e39142. PubMed ID: 39183421 [TBL] [Abstract][Full Text] [Related]
17. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial. Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933 [TBL] [Abstract][Full Text] [Related]
18. Study protocol for assessment of the efficacy of calcium dobesilate versus placebo on SARS-CoV-2 viral load in outpatients with COVID-19 (CADOVID study): a randomised, placebo-controlled, double-blind, monocentric phase II trial. Salamun J; Da Silva T; Ustero P; Gosmain Y; Guessous I; Calmy A; Spechbach H BMJ Open; 2024 May; 14(5):e079574. PubMed ID: 38719313 [TBL] [Abstract][Full Text] [Related]
19. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial. Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777 [TBL] [Abstract][Full Text] [Related]